 Home > News > Pharma News > 3700 hospitals cancel the supplement of consumables, the distributor's winter is coming

3700 hospitals cancel the supplement of consumables, the distributor's winter is coming

 ECHEMI 2019-06-24

On June 12, the curtain of the reform of medical consumables will be opened. The policy of increasing the price of consumables in medical institutions will be cancelled and the fees will be charged according to the purchase price. On June 10, the Beijing Municipal Government held a media ventilation meeting to introduce the related situation of the comprehensive reform of medical consumption linkage to be launched in Beijing at 0:00 on June 15. At the meeting, Lei Haichao, Secretary of the Party Committee of the Beijing Health and Health Commission, introduced the main contents of the reform as "Five Ones".

Among them, the most noticeable and the most changeable one is to cancel the 5% or 10% price increase policy of medical consumables in medical institutions and charge them according to the purchase price of medical consumables.

According to the previous regulations, the consumables used by medical institutions can be added 5% to 10% on the basis of the purchase price, among which the consumables whose price is more than 500 yuan can be added 5% and those whose price is less than 500 yuan can be added 10%. It is expected that after the reform, the price of medical consumables will be lowered,

< div>

< div> < div>

< div> the scope of the comprehensive reform of medical consumption linkage is the public medical institutions and military medical institutions run by the government, public institutions and state-owned enterprises in Beijing. Social medical institutions purchased by the government and designated social medical institutions with basic medical insurance shall apply voluntarily for participation. According to statistics, nearly 3700 medical institutions in the city participated in the reform. Because the medical reform is to cancel the consumption bonus, the information system used by medical institutions may be upgraded. Lei Haichao of

< div> < div> said that in 2017, Beijing began to implement the policy of separating medicine from medicine, abolished the mechanism of drug addition, and the construction of graded diagnosis and treatment system advanced a great step forward, with the growth of primary medical and health services nearly 30%. The purpose of this reform is to strengthen public welfare, standardize medical service items such as surgery, pathology and laboratory, and smooth the price-comparison relationship among service items. < div > < div > < / div > < div > consumables withdraw from the historical stage for profit < / div > < div > < div > < / div > < div > thunder tide introduction, after the beginning of this reform, medical institutions will no longer charge any additional fees for medical consumables. The abolition of such compensation mechanism, the abolition of additions to drug consumables and the reduction of part of the cost of inspection mean that medical consumables such as prescription of drugs, use of stents and catheters will no longer bring additional benefits to medical institutions. Promote the rational use of laboratory and medical consumables, standardize the service behavior of medical personnel, and reduce waste. At present, Beijing-Tianjin-Hebei medical consumables joint procurement has completed the procurement of six types of consumables, such as artificial joints and intracardiac vascular stents, with an average price drop of 15.5%, which can save about 500 million yuan for medical consumables in Beijing in one year. It is worth mentioning that the reform will eliminate the price difference between imported reagents and domestic reagents and different testing methods in reducing the price of large-scale equipment inspection projects, which means that patients will have more choices to go to hospitals and use the same price as before.

adjustment of medical service price

reform of joint procurement of consumables in Beijing began to preheat in May.

On May 6, the Beijing Medical Security Working Conference held in 2019 pointed out that the comprehensive reform of medical consumption linkage will be implemented in mid-June. In terms of price management, the reform involves a large number of projects with great changes. The total number of projects adjusted by the new norms will reach more than 6600.

< div>

< div> This is the first large-scale adjustment of the medical service price in Beijing in 20 years. After the adjustment of the medical service price, the change of the medical income structure of 100 yuan will follow. It is well known that the medical income of $100 includes the expenses of medicine, consumables and medical services. According to the rigid requirements of the state, the proportion of consumables income to the medical income of $100 should not exceed $20.

Several hospitals in Guangzhou have asked suppliers to reduce the price or consumption of consumables because of the high proportion of consumables. On April 22, the Affiliated Hospital of Guangdong Medical University informed the hospital supplier that all medical consumables used in orthopaedics, interventions and surgery should be renegotiated. The bargaining standard is to reduce the current purchase price by no less than 30%. Requirements are also made in the deadline of

and suppliers are required to submit the "promise of reducing the price of medical consumables" within one week. Failure to submit the "promise of reducing the price of medical consumables" within the deadline will be regarded as a waiver of supply qualification and related products will be directly discharged from the hospital. For this reason, a medical device salesman in Guangdong province said that he had just dropped 10% last year, and now he has reduced his demand by another 30%. Thus, some products can not be supplied. The same situation happened in February this year when CyberBlue instruments came from people who knew about them.

The same situation happened in February this year.

 Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Shanghai Pharmaceutical Bureau: 7 batches of drug don't meet the requirements

A protein may help prevent radiation damage

Comment

Comment

You May Interested In

buy Top Quality Tirzepatide Powder With Consistent Purity Weight Loss CAS 2023788-19-2

99% High-Purity GLP-1 Peptides | Retatrutide 10mg 15mg 20mg 30mg Vials | Lyophilized Powder | Weight Loss Retatrutide Peptide-Your Reliable Weight Los

$194.75/UNIT FOB

Changsha Duole Technology Co., Ltd

SO9001 factory high purity Tirzepatide 20mg 30mg 40mg 50mg 60mg freeze-dried powder for export, CAS#2023788-19-2

$90/G FOB

Changsha Caoquan Technology

Manufacturer Supply 99% High Quality Mots C/Tirze/Cagri/Ghk-Cu/Nad+ Reta CAS 1627580-64-6

$75/UNIT FOB

Changsha Caoquan Technology





Daily Morning Brief

2026-07-19

Taco Bell Lettuce Confirmed Source of Cyclospora Outbreak Across Five U.S. States

RPM International Names Polanco and Nicholson to VP Roles

Hungary Crackdown on $20 Billion EV Sector Puts China on Notice

Yara flags July uptick in fertilizer buying as Q2 profit, sales improve

North Carolina Resident Discovers Chemours Settled PFAS Lawsuit After 8-Year Wait

View All

Life Sciences Industry Overview

The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.

Published in: June.2026

Read Now Download

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Recommend Reading

Hot Searches: mirtazapine brand name; diclofenac sodium 75 mg; subtrochanteric fracture; tert butyl alcohol; cro3; oleate; hydrofluoric acid formula; barium bromide; n2o5 compound name; magnesium fluoride; nicotine patch drug class; janoshik testing



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.

3700 hospitals cancel the supplement of consumables, the distributor's winter is coming

Shanghai Pharmaceutical Bureau: 7 batches of drug don't meet the requirements

A protein may help prevent radiation damage

You May Interested In

Top Quality Tirzepatide Powder With Consistent Purity Weight Loss CAS 2023788-19-2

β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9

Semaglutide CAS 910463-68-2 99% purity GLP-1 Factory Supply Big Promotion 10mg

99% High-Purity GLP-1 Peptides | Retatrutide 10mg 15mg 20mg 30mg Vials | Lyophilized Powder | Weight Loss Retatrutide Peptide-Your Reliable Weight Los

SO9001 factory high purity Tirzepatide 20mg 30mg 40mg 50mg 60mg freeze-dried powder for export, CAS#2023788-19-2

Manufacturer Supply 99% High Quality Mots C/Tirze/Cagri/Ghk-Cu/Nad+ Reta CAS 1627580-64-6

Life Sciences Industry Overview

Related News

Recommend Reading